Hi, How Can We Help?
Advertisement
5

How quickly does glaucoma usually progress if untreated? 

Posted:    Author:  

Harry Whitmore, Medical Student

   Reviewed by:  

Dr. Stefan Petrov, MBBS

Glaucoma is generally a slow-moving disease that develops over several years, but its rate of progression can vary significantly depending on the type of glaucoma and individual risk factors. Because it typically causes a gradual loss of peripheral vision that the brain compensates for, many people do not notice any change in their sight until the condition is quite advanced. If left entirely untreated, chronic forms of glaucoma will eventually lead to permanent blindness as the optic nerve fibres are systematically destroyed by intraocular pressure or vascular insufficiency. While the timeline from initial damage to total sight loss often spans fifteen to twenty years, some aggressive forms or late-stage cases can deteriorate much more rapidly. Understanding this timeline is vital for appreciating why early clinical intervention is the only way to arrest the silent decline of a person’s visual field. 

What We’ll Discuss in This Article 

  • The average timeline for vision loss in untreated chronic glaucoma. 
  • Factors that influence the speed of optic nerve damage. 
  • The difference in progression rates between open-angle and acute angle-closure glaucoma. 
  • How late-stage glaucoma can accelerate in its final phases. 
  • The role of intraocular pressure levels in determining the speed of decline. 
  • Why regular monitoring is the only way to track a “silent” rate of change. 
  • Frequently asked questions regarding the prevention of rapid vision loss. 

The Timeline of Chronic Glaucoma Progression 

For most patients in the United Kingdom, glaucoma follows a chronic, slow-moving course. In primary open-angle glaucoma, the most common variant, the increase in eye pressure is often so subtle that it takes several years for the first measurable blind spots to appear in the peripheral vision. Research into the natural history of the disease suggests that, without any medical intervention, it can take roughly ten to fifteen years for a patient to move from the very earliest stages of nerve thinning to significant, life-altering visual impairment. This slow pace is what makes the disease so dangerous, as it allows the condition to remain “hidden” while permanent damage is being done. 

However, this average timeline is not a guarantee of safety. The speed of progression is not always linear; it can start slowly and then pick up pace as the optic nerve becomes increasingly fragile. According to clinical data shared by The Royal College of Ophthalmologists, the rate of loss varies between individuals, with some “fast progressors” losing vision much more quickly than others. Because there is no way for a patient to feel how fast their nerve is thinning, clinicians use repeated visual field tests and nerve scans over several months to calculate the specific “rate of change” for everyone. 

Factors That Accelerate Vision Loss 

Several factors can cause glaucoma to progress more rapidly than the average timeline. The most significant factor is the level of intraocular pressure. While a slightly elevated pressure might cause slow damage, very high pressure (for example, above 30 mmHg) can lead to much faster destruction of the optic nerve fibres. Similarly, the “fragility” of the nerve plays a role; an older optic nerve or one with a poor blood supply may deteriorate more quickly even at lower pressure levels. This is often seen in normal-tension glaucoma, where vascular issues like low blood pressure can accelerate the decline. 

Ethnicity and genetics also influence the speed of the disease. Individuals of African or Caribbean descent often experience an earlier onset and a more aggressive form of open-angle glaucoma that can lead to blindness in a shorter timeframe if not managed aggressively. Furthermore, if a person is diagnosed at a later stage meaning they have already lost a large portion of their nerve fibres the remaining fibres are often under greater stress and may fail more quickly. This “snowball effect” in the late stages of the disease is a primary concern for ophthalmologists, as it leaves very little margin for error in treatment. 

Acute vs Chronic Progression Rates 

It is essential to distinguish between the slow progression of chronic glaucoma and the lightning-fast progression of acute angle-closure glaucoma. While chronic forms take years to cause blindness, an acute attack is a medical emergency that can lead to permanent sight loss in just a few hours or days. In these cases, the drainage angle of the eye becomes suddenly and completely blocked, causing the pressure to spike to extreme levels. This sudden pressure surge is physically painful and causes immediate, noticeable symptoms such as redness and blurring, but the speed of the resulting nerve damage is devastating. 

In the UK, the NHS categorises acute angle-closure as a sight-threatening emergency. Because the damage happens so quickly, there is no “timeline” of years; the window for saving the patient’s vision is measured in hours. This contrast highlights that while “glaucoma” is often thought of as a slow disease, the anatomy of the eye can sometimes lead to a rapid crisis. Fortunately, acute cases are much rarer than chronic ones, but they serve as a reminder that any sudden change in vision or eye pain requires immediate clinical evaluation. 

Monitoring the Rate of Change 

Because you cannot feel the speed at which glaucoma is progressing, UK specialists rely on longitudinal monitoring to determine how quickly a patient is losing ground. This involves comparing the results of several tests over time usually every six to twelve months. If a patient’s visual field test shows new blind spots or if an OCT scan shows continued thinning of the retinal nerve fibre layer despite treatment, the disease is progressing. This “rate of change” data is more important than any single one-off reading, as it tells the doctor whether the current treatment is sufficient to protect the patient’s sight for the rest of their life. 

For many patients, the goal is not to “cure” the glaucoma, but to slow it down to a rate where they will never notice the vision loss during their lifetime. For example, if a 70-year-old patient has a very slow rate of progression, they may never experience significant disability. However, if a 40-year-old has the same rate of change, they are at much higher risk of going blind later in life and require more intensive intervention. This age-adjusted approach to progression is a fundamental part of NICE guidelines, ensuring that treatment is tailored to the individual’s risk of future blindness. 

The Final Stages of Untreated Glaucoma 

In the final stages of untreated glaucoma, the progression often appears to accelerate. This is partly because the central vision, which is the last to go, is the part of our sight we are most conscious of. When the peripheral vision is almost entirely gone a state known as tunnel vision the remaining central nerve fibres are all that are left to provide visual information. If these final fibres fail, the patient moves from having “poor” vision to total blindness. This final transition can feel sudden to the patient, even though it is the result of years of silent decay. 

Once total blindness occurs due to optic nerve death, it is irreversible. There are currently no medical or surgical treatments that can restore sight once the nerve fibres have been lost. This is the ultimate reason why the “speed” of glaucoma is so heavily discussed in clinical settings. The entire purpose of the UK’s screening and treatment infrastructure is to identify the disease while it is still in its slow, early phase, allowing clinicians to hit the “brakes” on the progression before the patient reaches these devastating final stages. 

Glaucoma Type Typical Progression Speed Time to Significant Loss (Untreated) 
Primary Open-Angle Very Slow 10 to 20 years 
Normal-Tension Slow to Moderate 10 to 15 years 
Chronic Angle-Closure Moderate 5 to 10 years 
Secondary (e.g. Injury) Variable Months to Years 
Acute Angle-Closure Extremely Rapid Hours to Days 

Conclusion 

If left untreated, chronic glaucoma usually progresses slowly over a decade or more, silently eroding the peripheral vision until total blindness occurs. The rate of this progression is influenced by factors such as eye pressure levels, age, and ethnicity, but it is always irreversible once the damage is done. While most cases move slowly, the lack of early symptoms makes regular professional screening the only effective way to catch the disease before it gathers momentum. If you experience severe, sudden eye pain, redness, or a rapid loss of vision, call 999 immediately. 

Can glaucoma progression be stopped entirely? 

While “stopped” is a strong word, treatment can slow the progression so significantly that most patients will never experience noticeable vision loss in their lifetime. 

How do I know if my glaucoma is moving fast?

You cannot know this yourself; it requires a specialist to compare your eye scans and visual field tests over a period of several months.

Does high blood pressure make glaucoma move faster?

While not a direct cause, poorly controlled blood pressure can affect the blood supply to the optic nerve, potentially speeding up the damage. 

Why does it take so long to go blind from glaucoma?

Because the optic nerve has over a million fibres, and it takes time for a significant enough number of them to die before the vision is noticeably affected. 

Can stress speed up the progression?

There is no direct clinical evidence that psychological stress speeds up nerve damage, though it can cause temporary spikes in eye pressure.

What is a “fast progressor”?

This is a clinical term for a patient whose nerve damage is occurring much more quickly than the average, often requiring more aggressive surgery or medication.

Is the rate of progression the same in both eyes? 

Usually no; it is common for one eye to progress faster than the other, though both eyes are typically affected eventually. 

Authority Snapshot 

This article examines the clinical timelines and progression rates associated with untreated glaucoma within the UK population. All information is based on the established medical standards and longitudinal studies recognised by the NHS and the Royal College of Ophthalmologists. Dr. Stefan, a London-based General Practitioner, has reviewed this content to ensure it provides accurate, evidence-based guidance on the importance of early detection and the risks of delayed treatment.

Advertisement
Leafease mob
Written By Harry Whitmore, Medical Student
Dr. Stefan Petrov, MBBS
Reviewed By Dr. Stefan Petrov, MBBS

Dr. Stefan Petrov is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 
Advertisement
2
weightfall desk